Hans Moebius - Oct 13, 2022 Form 4 Insider Report for Athira Pharma, Inc. (ATHA)

Role
Chief Medical Officer
Signature
/s/ Glenna Mileson, Attorney-in-Fact for Hans Moebius
Stock symbol
ATHA
Transactions as of
Oct 13, 2022
Transactions value $
$10,639
Form type
4
Date filed
10/17/2022, 06:06 PM
Previous filing
Jun 30, 2022
Next filing
Nov 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATHA Common Stock Options Exercise $10.6K +7.88K +14.88% $1.35 60.8K Oct 13, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATHA Stock Option (Right to Buy) Options Exercise $0 -7.88K -50% $0.00 7.88K Oct 13, 2022 Common Stock 7.88K $1.35 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth of the shares subject to the option vested on June 1, 2020 and one-fourth of the shares subject to the option vest on each year thereafter.